These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2014-004371-22 Phase IV study to assess, the effect of hepatic impairment on the pharmacokinetics of Thiotepa and the potential of Thiotepa to alter the QT interval in pedatric patients undergoing allogeneic haemato... bad-data
Reported results 2015-001360-19 Prospective, phase II/III, randomized clinical study to compare BEGEDINA® versus "conventional treatment" for treating steroid resistant acute graft-versus host disease Studio clinico randomizzato ... 2018-07-31 due-trials
Exempt 2017-002715-34 A Phase I/II, open label, dose escalation study to investigate the pharmacokinetics, pharmacodynamics, safety and clinical activity of begelomab as an initial treatment of acute Graft-versus-Host Dise... not-yet-due
Ongoing 2021-000898-83 A phase II, randomized, double-blind, placebo-controlled, two-period, crossover trial to assess the efficacy and safety of begelomab in combination with standard steroid and/or immunosuppressant thera... not-yet-due